论文部分内容阅读
目的在朝觐人群中使用口服rBS/WC疫苗(可唯适)预防霍乱和旅行者腹泻等肠道传染病的有效性和意义进行验证。方法选择各地2009年拟去麦加朝觐的朝圣者12730人,按标准选择作为本次开展口服可唯适疫苗试验的人群,全程规范接种疫苗并对部分朝觐人员观察预防效果。结果口服可唯适疫苗试验的人群未见任何不良反应,未发生大面积肠道感染引起的腹泻。结论可唯适疫苗在预防旅行者感染性腹泻是安全有效的。
Objectives To validate the effectiveness and significance of oral rBS / WC vaccine (which may be appropriate) to prevent intestinal infectious diseases such as cholera and traveler’s diarrhea among pilgrims. Methods Select 12,730 pilgrims who plan to go to Hajj in Mecca in 2009 and choose the standard of choice as the target group to conduct the oral vaccine trial. They will standardize the vaccination and observe the preventive effect on some pilgrims. Results Oral vaccine can only vaccine test the population did not see any adverse reactions, no large-scale intestinal infections caused by diarrhea. Conclusion Vaccine can be safe and effective in preventing infectious diarrhea in travelers.